In head and neck cancer, Prince et al. were the first to demonstrate that the population of HNSCC cells possess the properties of CSC [66], but a relatively high number of CD44+ cancer cells (>5,000 cells) are needed to generate new tumors in immunodeficient mice. The gene discussed is CD44; the disease is head and neck cancer.